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Abstract 
Purpose: To investigate the effect of ursolic acid florotriazole (UFT), on SCC-15 oral squamous cancer 
cells.  
Methods: Confocal laser microscope with a 490 nm argon laser was used to record the fluorescence of 
the cells and capture the images. Flow cytometry and Cell Quest program were used to analyze the 
DNA content of the stained cells. Apoptosis was characterized by YO-PRO-1 staining.  
Results: Treatment of SCC-15 cells with UFT for 48 h significantly reduced cell viability in a dose-
dependent manner. At 20 µg/mL concentration of UFT, SCC-15, cell viability was reduced to 19 % 
compared to 100 % in the untreated cells (p = 0.0002). UFT treatment enhanced the proportion of 
apoptotic cells which was evident from YO-PRO-1 staining. In UFT-treated cultures, the population of 
cells in sub-G1 phase increased to 38.54 % compared to 7.32 % for control after 48 h. Expression of 
Fas in UFT-treated cells was also higher (p = 0.0002) than in untreated cells. In C3H/HeJ mice, 
administration of UFT daily for 14 days caused a significant (p = 0.0002) reduction in tumor volume and 
weight after 30 days of SCC-15 carcinoma cell administration.  
Conclusion: UFT treatment inhibits viability and induces apoptosis in squamous cell carcinoma cells 
through suppression of Fas expression. Therefore, UFT may be useful for the treatment of squamous 
cell cancer.  
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Squamous cell carcinoma is the commonly 
observed malignant tumor of mucosa lining of the 
oral cavity. In Korea squamous cell carcinoma 
accounts for more than 90 % of the detected 
malignant tumors of the oral cavity [1]. Despite 
advancement in the fields of chemotherapy, 
radiation therapy and surgery, the prognosis of 
oral squamous cell cancer patients remains poor 
[2]. The five year survival rate of oral squamous 
cell cancer patients has been observed to be 50 
% [2]. Taking into consideration the poor survival 
rate, the discovery of drugs for the treatment of 
patients with squamous cell carcinoma is 
desperately required. 
 
Apoptosis, the programmed and controlled 
process of cell death is regulated by both internal 
as well as external signals. It plays an important 
role in the development and maintenance of 
multicellular organisms by eliminating unwanted 
cells from the body [3]. Apoptotic cells are 
characterized by morphological alterations 
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including, decreased cell and nucleus sizes, 
blebbing of plasma membrane, condensation of 
chromatin and DNA fragmentation [4]. Induction 
of apoptosis in carcinoma cells by treatment with 
chemotherapeutic agents is a promising strategy 
for cancer treatment [5,6]. 
 
Ursolic acid (UA), belonging to the terpenoid 
family of natural products is a pentacyclic 
molecule abundantly present in the plant 
kingdom [7-10].  It is a biologically active 
compound and has medicinal importance in 
traditional Chinese medicine for the clinical 
treatment of various diseases. UA exhibits a 
broad spectrum of activities including, as anti-
inflammatory, antiviral, antioxidant, 
hepatoprotective, cytotoxic, antitumor, anti-
angiogenesis, and anti-metastatic activities [11]. 
It has also been demonstrated that UA causes 
inhibition of colon carcinoma cell proliferation and 
induces apoptosis [12,13-15].  
 
It was reported that the triazole analogs of UA 
are more potent compared to the parent 
compound. In the present study, the effect of 
ursolic acid floro triazole (UFT) on oral squamous 
cancer was investigated. The results revealed a 
significant reduction in cell viability, induction of 
apoptosis, cell cycle arrest and reduction in 




Drug and chemical  
 
Ursolic acid florotriazole (UFT) was synthesized 
using a previously reported procedure from the 
parent ursolic acid using reported procedure [13]. 
UFT was dissolved in DMSO to prepare the 




Female C3H/HeN mice (8 weeks old) were 
purchased from the Laboratory Animal Center, 
Third Military Medical University (Chongqing, 
China). The animals were housed under 12 h 
light and dark cycle in pathogen‑free 
environment, with access to water and food ad 
libitum.  
 
All the animal experiments were performed 
according to the Kyung Hee University 
Institutional Animal Care and Use Committee 
guidelines. The study was approved by the ethics 
committee of Kyung Hee University Institutional 





SCC-15 human squamous cell carcinoma cell 
line was purchased from The Cell Bank of Type 
Culture Collection of Chinese Academy of 
Sciences, Shanghai Institute of Cell Biology 
(Shanghai, China). The cells were maintained at 
37 ˚C in an atmosphere of 5 % CO2 in RPMI-
1640 medium (Thermo Fisher Scientific Inc., 
Waltham, MA, USA). The study was approved by 
the Ethics Committee of Kyung Hee University 




Into the 96-well flat bottom multiplates (BD 
Falcon, Franklin, NJ) cells at a density of 2.5 x 
105 cells per well were distributed. To each of the 
well different concentration of UFT was added 
and incubated for 48 h.  MTT (Sigma-Aldrich, St. 
Louis, MO, USA) solution (10 μL) was added to 
each well and the plates were incubated for 4 h 
at 37 oC in 5 % CO2 incubator. Formazan 
crystals were dissolved by adding 0.04 N HCl in 
2-propanol (100 μL). The microplate reader 
(MPR-A4i; Tosoh Corporation, Tokyo, Japan) 
was used to measure absorption at 570 nm. All 




SCC-15 cells at a density of 2 x 106 cells per well 
were distributed onto 6-well plates (Nunc A/S) 
containing RPMI-1640 supplemented with 2 % 
FBS. Following 24 h incubation, the cells were 
treated with a range of UFT concentrations (2, 5, 
10, 20 and 30 µg/mL). After 48 h, the cells were 
washed twice with ice-cold PBS, treated with 20 
µL PBS and subsequently stained for 30 min with 
0.2 µM YO-PRO-1 (Molecular Probes Inc., 
Eugene, OR, USA) dye. The confocal laser 
microscope (LSM 510 Meta; Carl Zeiss, 
Oberkochen, Germany) with a 490 nm argon 
laser was used to record the fluorescence of the 
cells and capture the images.  
 
Cell cycle analysis 
 
In 100 mm culture dishes, SCC-15 cells were 
distributed at a density of 2 x 105 cells per well 
and incubated with various concentrations of 
UFT for 48 h. The cells were then harvested, 
centrifuged for 10 min at 500 x g and 
subsequently rinsed in ice‑cold PBS. The cells 
were fixed in 70 % ethyl alcohol and stored for 2 
h at -20 ˚C. Followed PBS washing, the cells 
were put in 200 µL PI/RNase Staining Buffer (BD 
Biosciences) for 1 h under dark conditions. 
FACSVantage SE flow cytometry system and 
CellQuest program (BD Biosciences) were used 
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for the analysis of DNA content of the stained 
cells.  
 
Reverse transcription (RT)‑PCR  
 
The cells were cultured in medium containing 
UFT followed by RNA extraction using Isogen 
systems reagents (Nippon Gene Co., Ltd., 
Tokyo, Japan). Following denaturation by heating 
at 60 ˚C for 30 min using 500 pmol oligo(dT) 
primer, RNA was reverse-transcribed to cDNA. 
The reverse-transcription solution comprised of 
Moloney murine leukemia virus reverse 
transcriptase (Invitrogen Japan K. K., Tokyo, 
Japan), 75 mm KCl, 50 mm Tris-HCl (pH 8.3), 3 
mm MgCl2, 0.01 M DTT, 0.5 mm of each dNTP 
and 16 units RNasin® (Promega Corporation, 
Madison, WI, USA). Quantitative PCR and BI 
Prism 7700 Sequence Detector (TaqMan; PE 
Biosystems Japan, Tokyo, Japan) were used for 
the amplification of cDNA. The reaction was 
performed in a 50 µL reaction mixture containing 
200 nM forward and reverse primers, 100 nM 
probe specific for the targeted cDNA and 
TaqMan Universal Master mix (PE Biosys- tems 
Japan). The data were examined using 
Sequence Detection software (PE Biosystems 
Japan). The primers and probes for amplifying 
Fas were purchased from PE Biosystems Japan. 
Target gene expression levels were standardized 
to the internal standard gene expression levels. 
The relative expression levels of Fas in the UFT-
treated cells were compared with the levels in the 
untreated cells. Enhanced chemiluminescence 
system was used for visualization of 
immunoreactive bands. 
 
Tumor growth in in vivo SCC-15 animal model 
 
To establish an in vivo SCC-15 animal model, 2 x 
105 SCC-15 cells in 100 µL PBS were 
subcutaneously injected into the right flank of the 
C3H/HeJ mice. After five days, when the tumors 
formed visible masses, the animals were divided 
into two groups, each containing 5 mice. The 
animals in treatment group were injected 
intraperitoneally 20 mg/kg body weight of UFT 
daily in the morning for 15 days whereas the 
animals in control group received PBS. On day 
30 following carcinoma cell administration, the 
animals were euthanized using CO2 and the 
tumors were extracted and weighed. The volume 
of the tumor was determined after measurement 




For the purpose of statistical analysis, Mann-
Whitney U test was used. Student’s t-test was 
used for statistical analysis of the effect of UFT 
on cancer cell proliferation and the alteration of 
mRNA expression in vitro. P < 0.05 was 





Suppression of SCC-15 cell viability by UFT 
 
The effect of various concentrations (0, 2, 5, 10, 
15, 20 and 30 µg/mL) of UFT on the viability of 
SCC-15 cells was evaluated by MTT assay. The 
results revealed a concentration dependent 
reduction in the viability of SCC-15 cells on 
treatment with UFT for 48 h. Among the various 
concentrations of UFT tested, the reduction in 
cell viability was maximum at 20 µg/mL 
concentration after 48 h. At 20 µg/mL 
concentration of UFT, SCC-15 cell viability was 
reduced to 19 % compared to the untreated cells 
(p = 0.0002, Figure 1). 
 
 
Figure 1: Effect of UFT on the viability of SCC-15 
cells. The cells after treatment with 2, 5, 10, 15, 20 
and 30 µg/mL concentrations of UFT for 48 h were 
analyzed for viability using MTT assay. The data 
expressed are the mean ± standard deviation for three 
experiments. UFT, stands for ursolic acid florotriazole 
 
Induction of apoptosis in SCC-15 cells by 
UFT 
 
Induction of apoptosis in SCC-15 cells by UFT 
treatment was examined using YO‑PRO‑1 dye 
followed by confocal microscopy. The results 
showed a significant increase in the proportion of 
apoptotic cells with increase in the concentration 
of UFT from 5 to 20 µg/mL (Figure 2). 
 
UFT increased the number of cells in sub-G1 
phase 
 
Analysis of cell cycle using flow cytometry after 
PI staining revealed a significant increase in the 
proportion of cells in sub-G1 phase (Figure 3A). 
UFT treatment at 20 µg/ml increased the 
proportion of cells in sub-G1 phase to 38.54 % 
compared to 7.32 % in the control cells after 48 
h. 
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Figure 2: Effect of UFT on the induction of apoptosis in SCC‑15 cells using YO‑PRO‑1 staining. The cells 
following 2, 5, 10, 15 and 20 µg/mL concentrations of UFT treatment were stained with YO‑PRO‑1 and imaged by 
confocal microscope. UFT, stands for ursolic acid florotriazole 
 
 
Figure 3: Analysis of SCC-15 cell cycle by flow cytometric analysis. UFT treatment increased the population of 
SCC-15 cells in sub-G1 phase of cell cycle. DNA content of SCC-15 cells after treatment with 20 µg/mL of UFT 
for 48 h were analyzed by flow cytometry following propidium iodide staining 
 
Effect of UFT treatment on the expression of 
Fas gene in SCC-15 cells 
 
Expression of Fas gene in SCC-15 cells was 
determined by RT-PCR. The results showed a 
significant increase in the expression of Fas on 
treatment with 20 µg/mL concentration of UFT 
compared to that of untreated cells (Figure 4). 
The increase in the expression of Fas by UFT 
treatment was further confirmed using western 
blot analysis (Figure 4). These data indicate that 
UFT increases the expression of Fas in SCC-15 
cells. 
 
UFT treatment inhibits tumor growth in an 
SCC-15 animal model 
 
The antitumor activity of UFT treatment was 
examined in an SCC-15 animal model using 
C3H/HeJ mice. At five days after subcutaneous 
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implantation of SCC-15 cells, the mean tumor 
volume was ~10 mm3. In the control (PBS-
treated) group, the tumors grew rapidly and 
reached an average volume of 501 ± 43.9 mm3 
(mean ± SD) on day 14 after inoculation with 
SCC-15 cells (Figure 5A). The mean size of the 
primary tumor in animals treated with 10 mg/kg 
UFT was determined to be 202 ± 20.2 mm3 at 14 
days. Similarly, the mean tumor weight for the 
animals treated with 10 mg/kg UFT 46.2 % of 
that in the control group (Figure 5B). Together, 
these results indicate that UFT inhibited tumor 
growth in the SCC-15 animal model. 
 
 
Figure 4: Effect of UFT on the Fas expression. The expression of Fas gene was analyzed by semi-quantitative 
reverse transcription-polymerase chain reaction whereas that of Fas protein by western blots analysis. The 





Figure 5: UFT treatment inhibits the growth and weight of tumor in SCC-15 animal model. 2 x105 SCC-15 cells 
in PBS were administered into the right flanks of C3H/HeJ mice. The mice were treated with UFT for 15 days and 
were then sacrificed after 30 days. The volume and weight of tumor was measured. The data expressed are the 
mean ± standard deviation of triplicate experiments 
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The present study demonstrates effect of UFT on 
the cell viability, induction of apoptosis and the 
mechanism underlying the in vitro inhibition of 
oral squamous cancer cells as well as in vivo 
mouse model. It was observed that UFT 
treatment inhibited SCC-15 cell viability, induced 
apoptosis, and increased the proportion of cells 
in sub-G1 phase. In addition, the tumor volume 
and weight in the UFT-treated mice were also 
reduced significantly compared to the untreated 
mice. 
 
Inhibition of the viability of carcinoma cell lines by 
chemotherapeutic agents can be a promising 
strategy for the treatment of cancers. The results 
from the present study showed that UFT 
exhibited a concentration dependent inhibitory 
effect on the viability of SCC-15 cells following 
exposition for 48 h. UFT treatment increased the 
proportion of apoptotic cells significantly 
compared to the untreated cells. Analysis of cell 
cycle revealed a marked increase in the 
population of cells in sub-G1 phase with increase 
in the concentration of UFT to 20 µg/mL. It is 
reported that Fas exhibits a vital role in the 
induction of cell apoptosis in various types of 
carcinoma cells through the caspase activation 
pathway [16]. UFT treatment for 48 h caused 
enhancement in the expression of Fas gene in 
SCC-15 cells significantly compared to the 
untreated control cells. Thus, UFT treatment 
leads to apoptosis in SCC-15 cells via Fas 
signaling pathway activation. In the present 
study, the antitumor activity of UFT was also 
investigated in a SCC-15 animal model using 
C3H/HeJ mice. Reduction in the tumor volume 
and weight has been observed in various types 
of mouse xenograft models including, renal and 
prostate carcinoma [17,18]. In the present study, 
it was observed that UFT treatment caused a 
significant suppression in the volume and weight 




The results from the present study reveal that 
UFT inhibited cell viability, induced apoptosis of 
oral squamous cell cancer cells, and suppressed 
tumor growth in vivo through Fas signaling 
pathway. Thus, UFT is a potent candidate for the 
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